246 related articles for article (PubMed ID: 9404706)
21. Management of Ontario children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocols.
Desai SJ; Barr RD; Andrew M; deVeber LL; Pai MK
CMAJ; 1989 Oct; 141(7):693-7. PubMed ID: 2790605
[TBL] [Abstract][Full Text] [Related]
22. Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements.
Pui CH; Chessells JM; Camitta B; Baruchel A; Biondi A; Boyett JM; Carroll A; Eden OB; Evans WE; Gadner H; Harbott J; Harms DO; Harrison CJ; Harrison PL; Heerema N; Janka-Schaub G; Kamps W; Masera G; Pullen J; Raimondi SC; Richards S; Riehm H; Sallan S; Sather H; Shuster J; Silverman LB; Valsecchi MG; Vilmer E; Zhou Y; Gaynon PS; Schrappe M
Leukemia; 2003 Apr; 17(4):700-6. PubMed ID: 12682627
[TBL] [Abstract][Full Text] [Related]
23. p16 inactivation associated with aggressive clinical course and fatal outcome in TEL/AML1-positive acute lymphoblastic leukemia.
Papadhimitriou SI; Polychronopoulou S; Tsakiridou AA; Androutsos G; Paterakis GS; Athanassiadou F
J Pediatr Hematol Oncol; 2005 Dec; 27(12):675-7. PubMed ID: 16344676
[TBL] [Abstract][Full Text] [Related]
24. [Detection of BCR/ABL, MLL/AF4 and TEL/AML1 hybrid genes and monitoring of minimal residual disease in pediatric patients with acute lymphoblastic leukemia].
Trka J; Zuna J; Haskovec C; Brabencová A; Kalinová M; Muzíková K; Paukertová R; Hrusák O; Zemanová Z; Michalová K; Starý J
Cas Lek Cesk; 1999 Jan; 138(1):12-7. PubMed ID: 10953429
[TBL] [Abstract][Full Text] [Related]
25. Intensified chemotherapy without SCT in infant ALL: results from COG P9407 (Cohort 3).
Dreyer ZE; Hilden JM; Jones TL; Devidas M; Winick NJ; Willman CL; Harvey RC; Chen IM; Behm FG; Pullen J; Wood BL; Carroll AJ; Heerema NA; Felix CA; Robinson B; Reaman GH; Salzer WL; Hunger SP; Carroll WL; Camitta BM
Pediatr Blood Cancer; 2015 Mar; 62(3):419-26. PubMed ID: 25399948
[TBL] [Abstract][Full Text] [Related]
26. Acute lymphoblastic leukemia in a developing country: preliminary results of a nonrandomized clinical trial in El Salvador.
Bonilla M; Moreno N; Marina N; deReyes G; Shurtleff SA; Downing JR; Behm FG; Harrison PL; Ribeiro RC; Peña O; Crist WM; Antillon FG
J Pediatr Hematol Oncol; 2000; 22(6):495-501. PubMed ID: 11132215
[TBL] [Abstract][Full Text] [Related]
27. High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation.
Marshall GM; Dalla Pozza L; Sutton R; Ng A; de Groot-Kruseman HA; van der Velden VH; Venn NC; van den Berg H; de Bont ES; Maarten Egeler R; Hoogerbrugge PM; Kaspers GJ; Bierings MB; van der Schoot E; van Dongen J; Law T; Cross S; Mueller H; de Haas V; Haber M; Révész T; Alvaro F; Suppiah R; Norris MD; Pieters R
Leukemia; 2013 Jul; 27(7):1497-503. PubMed ID: 23407458
[TBL] [Abstract][Full Text] [Related]
28. Outcome of recurrent or refractory acute lymphoblastic leukemia in infants with MLL gene rearrangements: A report from the Japan Infant Leukemia Study Group.
Tomizawa D; Koh K; Hirayama M; Miyamura T; Hatanaka M; Saikawa Y; Ishii E
Pediatr Blood Cancer; 2009 Jul; 52(7):808-13. PubMed ID: 19229974
[TBL] [Abstract][Full Text] [Related]
29. Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia.
Winick N; Shuster JJ; Bowman WP; Borowitz M; Farrow A; Jacaruso D; Buchanan GR; Kamen BA
J Clin Oncol; 1996 Oct; 14(10):2803-11. PubMed ID: 8874342
[TBL] [Abstract][Full Text] [Related]
30. [Acute lymphoblastic leukemia in infants--results of treatment according to infant leukemia protocol--POG 8493].
Sońta-Jakimczyk D; Armata J; Bogusławska-Jaworska J; Cyklis R; Chybicka A; Grześkowiak-Melanowska J; Radwańska U; Swiatły A; Wieczorek M
Acta Haematol Pol; 1993; 24(2):131-8. PubMed ID: 8372612
[TBL] [Abstract][Full Text] [Related]
31. Intensive alternating drug pairs after remission induction for treatment of infants with acute lymphoblastic leukemia: A Pediatric Oncology Group Pilot Study.
Lauer SJ; Camitta BM; Leventhal BG; Mahoney D; Shuster JJ; Kiefer G; Pullen J; Steuber CP; Carroll AJ; Kamen B
J Pediatr Hematol Oncol; 1998; 20(3):229-33. PubMed ID: 9628434
[TBL] [Abstract][Full Text] [Related]
32. Incidence of TEL/AML1 fusion in children with relapsed acute lymphoblastic leukemia.
Loh ML; Silverman LB; Young ML; Neuberg D; Golub TR; Sallan SE; Gilliland DG
Blood; 1998 Dec; 92(12):4792-7. PubMed ID: 9845546
[TBL] [Abstract][Full Text] [Related]
33. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.
Silverman LB; Gelber RD; Dalton VK; Asselin BL; Barr RD; Clavell LA; Hurwitz CA; Moghrabi A; Samson Y; Schorin MA; Arkin S; Declerck L; Cohen HJ; Sallan SE
Blood; 2001 Mar; 97(5):1211-8. PubMed ID: 11222362
[TBL] [Abstract][Full Text] [Related]
34. AML1 amplification in a child with acute lymphoblastic leukemia.
Alvarez Y; Coll MD; Bastida P; Ortega JJ; Caballín MR
Cancer Genet Cytogenet; 2003 Jan; 140(1):58-61. PubMed ID: 12550760
[TBL] [Abstract][Full Text] [Related]
35. Treatment of childhood acute lymphoblastic leukemia. Long-term results of the AIEOP-ALL 87 study.
Paolucci G; Vecchi V; Favre C; Miniero R; Madon E; Pession A; Rondelli R; De Rossi G; Lo Nigro L; Porta F; Santoro N; Indolfi P; Basso G; Conter V; Aricò M;
Haematologica; 2001 May; 86(5):478-84. PubMed ID: 11410410
[TBL] [Abstract][Full Text] [Related]
36. Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer Group.
Nachman J; Sather HN; Gaynon PS; Lukens JN; Wolff L; Trigg ME
J Clin Oncol; 1997 Jun; 15(6):2222-30. PubMed ID: 9196134
[TBL] [Abstract][Full Text] [Related]
37. In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype.
Ramakers-van Woerden NL; Beverloo HB; Veerman AJ; Camitta BM; Loonen AH; van Wering ER; Slater RM; Harbott J; den Boer ML; Ludwig WD; Haas OA; Janka-Schaub GE; Pieters R
Leukemia; 2004 Mar; 18(3):521-9. PubMed ID: 14712291
[TBL] [Abstract][Full Text] [Related]
38. 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia.
Pui CH; Behm FG; Downing JR; Hancock ML; Shurtleff SA; Ribeiro RC; Head DR; Mahmoud HH; Sandlund JT; Furman WL
J Clin Oncol; 1994 May; 12(5):909-15. PubMed ID: 8164041
[TBL] [Abstract][Full Text] [Related]
39. [The effect of polychemotherapy on hemopoiesis in acute lymphoblastic leukemia in children].
Vladimirskaia EB; Zamarraeva NV; Lebedev VV; Kryzhanovskiĭ OI; Rumiantsev AG; Sallakh S; Tabet S; Mazo IB
Gematol Transfuziol; 1993 May; 38(5):6-10. PubMed ID: 8034176
[TBL] [Abstract][Full Text] [Related]
40. Long-term outcomes of modified BFM-95 regimen in adults with newly diagnosed standard-risk acute lymphoblastic leukemia: a retrospective single-center study.
Li C; Cai X; Chen X; Liang Y; Xia Z; Wang H
Int J Hematol; 2019 Oct; 110(4):458-465. PubMed ID: 31321731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
